Quarterly report pursuant to Section 13 or 15(d)

Schedule of Effect of Restatement on Financial Statements (Details) (Parenthetical)

v3.23.1
Schedule of Effect of Restatement on Financial Statements (Details) (Parenthetical) - $ / shares
Mar. 31, 2022
Feb. 25, 2022
Feb. 24, 2022
Dec. 31, 2021
Preferred stock, par value $ 0     $ 0
Preferred stock, shares authorized 50,000,000     50,000,000
Common stock, par value $ 0.001     $ 0.001
Common stock, shares authorized 250,000,000 250,000,000 200,000,000 200,000,000
Common stock, shares issued 116,394,806     116,394,806
Common stock, outstanding 116,394,806     116,394,806
Series A Preferred Stock [Member]        
Preferred stock, shares issued 9,417,000     9,417,000
Preferred stock, shares outstanding 9,417,000     9,417,000